查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1886725

全球子宮內避孕器市場

Intrauterine Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球子宮內避孕器市場規模將達49億美元。

2024年全球子宮內避孕器市場規模估計為39億美元，預計2030年將達49億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為3.8%。本報告分析的細分市場之一－含激素黃體素子宮內避孕器，預計複合年成長率為3.4%，到分析期末將達34億美元。不含激素的含銅子宮內避孕器細分市場預計在分析期間內複合年成長率為4.8%。

美國市場規模估計為11億美元，而中國市場預計將以3.6%的複合年成長率成長。

據估計，2024年美國子宮內避孕器市場規模將達11億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到7.766億美元，在2024年至2030年的分析期內，年複合成長率（CAGR）為3.6%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，兩國的年複合成長率分別為3.5%和3.2%。在歐洲，德國的年複合成長率預計約為3.9%。

全球子宮內避孕器市場－主要市場趨勢與促進因素摘要

什麼是子宮內避孕器？為什麼它是一種流行的長期避孕方法？

子宮內避孕器（IUD）是一種小型T形避孕裝置，放置於子宮內以防止懷孕。其高效能、​​便捷和可逆性使其成為一種廣受歡迎的長期避孕方法。子宮內避孕器分為含激素型和非激素型；前者釋放少量黃體素以抑制排卵，後者通常由銅製成，可創造不利於精子生存的環境。由於子宮內避孕器可避孕數年，因此對於尋求長期、便捷避孕方式的女性來說，它是一個極具吸引力的選擇。此外，子宮內避孕器可隨時取出，迅速恢復生育能力，更提升了其便利性。隨著人們對子宮內避孕器益處的認知不斷提高，它正迅速成為全球女性首選的避孕方法。

科技進步如何影響子宮內避孕器市場？

技術創新正對子宮內避孕器市場產生重大影響，尤其是在避孕器設計、材料和安全功能方面的創新。現代子宮內避孕器旨在提高舒適度和易置性，有些型號體積更小，並採用更柔軟的材料，以減少置入過程中的不適感。激素釋放型子宮內避孕器的進步促成了低劑量激素緩釋型避孕器的研發，這些節育器可在更長時間內釋放更低劑量的激素，從而在保持有效性的同時降低副作用風險。此外，安全性更高的子宮內避孕器的推出，例如最大限度地降低穿孔和排放的風險，也促進了其普及。這些創新使子宮內避孕器更容易獲得，並受到更多女性的青睞，推動了市場成長。

避孕保健領域對子宮內避孕器的需求不斷成長，背後原因是什麼？

子宮內避孕器在避孕護理領域的需求不斷成長，主要源於人們對無需持續維護的長期可靠避孕方式日益成長的需求。隨著女性尋求每日口服避孕藥和注射、貼片等短期避孕方法的替代方案，子宮內避孕器提供了一種高效且幾乎無需後續維護的解決方案。此外，人們對子宮內避孕器長期健康益處的認知不斷提高，例如不影響母乳哺育以及可能降低某些癌症的風險，也推動了子宮內避孕器的需求成長。同時，全球延後生育的趨勢以及計劃生育服務的日益普及也促進了子宮內避孕器的普及。隨著越來越多的女性優先考慮有效、便捷且可逆的避孕方式，預計子宮內避孕器的需求將持續成長。

哪些因素正在推動子宮內避孕器市場的成長？

子宮內避孕器市場的成長受多種因素驅動，包括技術進步、消費者偏好變化以及避孕選擇的日益豐富。其中一個關鍵促進因素是子宮內避孕器設計和材料的改進，這些改進使避孕器更加舒適、安全和有效，從而吸引了更多女性的青睞。此外，人們對長期、便利的避孕方法的需求不斷成長也是推動市場成長的偏好之一。子宮內避孕器為每日避孕和短期避孕方法提供了可靠的替代方案。同時，計劃生育服務的普及以及全球對生殖健康和權利的計劃也促進了市場成長，使更多女性能夠獲得避孕服務。此外，人們對子宮內避孕器健康益處的認知不斷提高，例如其降低某些癌症風險的能力以及其對各類女性的適用性，也推動了子宮內避孕器的普及。隨著這些趨勢的持續發展，對有效、安全、便捷的避孕解決方案的需求預計將推動子宮內避孕器市場持續成長。

部分：

依類型（含荷爾蒙黃體素的子宮內避孕器、不含荷爾蒙的含銅子宮內避孕器）、年齡層（15-24歲、25-34歲、35-44歲、45歲以上）及用途（醫院、診所、社區健康中心、其他用途）分類。

受訪公司範例

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare（Monaco）
  • CooperSurgical, Inc.
  • Eurogine, SL
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有採用典型的 LLM 或產業專用的SLM 方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP12831

Global Intrauterine Devices Market to Reach US$4.9 Billion by 2030

The global market for Intrauterine Devices estimated at US$3.9 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Nonhormonal Copper-Containing IUD segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 3.6% CAGR

The Intrauterine Devices market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$776.6 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Intrauterine Devices Market - Key Trends & Drivers Summarized

What Are Intrauterine Devices and Why Are They a Popular Choice for Long-Term Contraception?

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices that are inserted into the uterus to prevent pregnancy. They are a popular choice for long-term contraception due to their high effectiveness, convenience, and reversibility. IUDs can be hormonal or non-hormonal, with the former releasing small amounts of progestin to prevent ovulation and the latter, typically made of copper, creating an environment that is toxic to sperm. IUDs provide protection against pregnancy for several years, making them an attractive option for women seeking long-term, hassle-free contraception. Their ability to be removed at any time, allowing for a quick return to fertility, further enhances their appeal. As awareness of the benefits of IUDs increases, they are becoming a preferred contraceptive method among women worldwide.

How Are Technological Advancements Shaping the Intrauterine Devices Market?

Technological advancements are significantly shaping the intrauterine devices market, particularly through innovations in device design, materials, and safety features. Modern IUDs are being designed to offer improved comfort and ease of insertion, with some models featuring smaller sizes and flexible materials to reduce discomfort during placement. Advances in hormonal IUDs have led to the development of devices that release lower doses of hormones over longer periods, reducing the risk of side effects while maintaining efficacy. Additionally, the introduction of IUDs with enhanced safety profiles, such as devices that minimize the risk of perforation and expulsion, is contributing to increased adoption. These innovations are making IUDs more accessible and appealing to a broader range of women, driving growth in the market.

Why Is There an Increasing Demand for Intrauterine Devices in Contraceptive Care?

The demand for intrauterine devices is increasing in contraceptive care due to the growing emphasis on long-term, reliable, and low-maintenance birth control options. As women seek alternatives to daily oral contraceptives and short-term methods like injections or patches, IUDs offer a highly effective solution that requires little ongoing maintenance. The rising awareness of the long-term health benefits of IUDs, such as their non-interference with breastfeeding and their potential to reduce the risk of certain cancers, is also driving demand. Additionally, the global trend towards delaying childbirth and the increasing availability of family planning services are contributing to the growing popularity of IUDs. As more women prioritize effective, convenient, and reversible contraception, the demand for IUDs is expected to continue to rise.

What Factors Are Driving the Growth in the Intrauterine Devices Market?

The growth in the intrauterine devices market is driven by several factors related to technological advancements, changing consumer preferences, and the increasing availability of contraceptive options. One of the primary drivers is the advancement in IUD design and materials, which has improved the comfort, safety, and efficacy of these devices, making them more attractive to a wider range of women. The growing preference for long-term, low-maintenance contraception is also fueling demand, as IUDs offer a reliable alternative to daily or short-term methods. The increasing availability of family planning services and the global push for reproductive health and rights are further contributing to market growth, as more women gain access to contraceptive options. Additionally, the rising awareness of the health benefits of IUDs, such as their potential to reduce the risk of certain cancers and their suitability for a wide range of women, is driving adoption. As these trends continue to evolve, the intrauterine devices market is expected to experience sustained growth, driven by the need for effective, safe, and convenient contraceptive solutions.

SCOPE OF STUDY:

The report analyzes the Intrauterine Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hormonal Progestogen-Releasing IUD, Nonhormonal Copper-Containing IUD); Age Group (15 - 24, 25 - 34, 35 - 44, Above 44); End-Use (Hospitals, Clinics, Community Healthcare Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare (Monaco)
  • CooperSurgical, Inc.
  • Eurogine, S.L
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Intrauterine Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Long-Acting Reversible Contraception Spurs Adoption of Intrauterine Devices (IUDs)
    • Advancements in IUD Technology Propel Innovation in Contraceptive Solutions
    • Shift Towards Non-Hormonal and Hormonal IUDs Expands Market Opportunities
    • Increasing Use of IUDs in Family Planning Programs Globally
    • Role of IUDs in Reducing Unintended Pregnancies
    • Advancements in IUD Insertion Techniques and Device Safety Propel Market Growth
    • Emerging Markets Present New Opportunities for IUD Manufacturers
    • Rise in Demand for Targeted Temperature Management Spurs Adoption of Intravascular Temperature Management Devices
    • Advancements in Cooling and Heating Technology Propel Innovation in Temperature Management
    • Shift Towards Minimally Invasive Temperature Regulation Expands Market Opportunities
    • Increasing Use of Intravascular Temperature Management in Post-Cardiac Arrest Patients
    • Growing Importance of Hypothermia Induction in Trauma and Surgery
    • Advancements in Catheter-Based Cooling and Warming Systems Propel Market Growth
    • Push for Cost-Effective and Efficient Temperature Management Solutions
    • Role of Intravascular Temperature Management in Improving Patient Outcomes
    • Growing Focus on Patient Safety and Reducing Complications
    • Integration of Temperature Management Devices with Advanced Monitoring Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intrauterine Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hormonal Progestogen-Releasing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Nonhormonal Copper-Containing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for 15 - 24 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for 25 - 34 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for 35 - 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Above 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Community Healthcare Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION